Epilepsia Partialis Continua 

  • Author: Claude G Wasterlain, MD; Chief Editor: Selim R Benbadis, MD   more...
 
Updated: Jun 8, 2011
 

Overview

In 1895, Kojewnikoff described a unique type of prolonged seizure, which he named epilepsia partialis continua (EPC). Since then, this name has been ascribed to various nosological entities, with the condition being described as a variation of jacksonian epilepsy, as a jacksonian status epilepticus, as myoclonus epilepsy, as an extrapyramidal syndrome, or as continuous, localized myoclonia.

Epilepsia partialis continua can be considered the status epilepticus equivalent of simple partial motor seizures. It manifests itself as focal motor clonic seizures without jacksonian march, seizures remain localized to the part of the body in which they originate, and motor activity is often persistent, lasting for at least 60 minutes and often for hours, days, weeks, or even longer. Consciousness usually is preserved, but postictal weakness is frequently evident.[1, 2]

In the vast majority of cases, the seizures are of cortical origin; however, subcortical mechanisms also have been proposed.[3]

EPC can be an expression of a stable neurologic lesion or a progressive disease, such as Rasmussen syndrome.[4]

Antiepileptic drugs, with a few notable exceptions, do not seem to significantly alter the course of this condition.[5]

While the localized nature of EPC is one of its most striking features, occasional spread is seen in otherwise typical cases, and using it as an exclusion criterion is not warranted.

Go to Epilepsy and Seizures, Status Epilepticus, and Partial Epilepsies for an overview of these topics.

Definition

The author defines epilepsia partialis continua as a form of partial status epilepticus with simple motor manifestations that are maintained for over 1 hour, with clonic activity restricted to 1 body part and recurring at fairly regular intervals. The following modifying factors apply:

  • Motor activity often is modified by sensory stimuli
  • Frequency is usually 0.1-6 Hz
  • An occurrence of EPC can continue for long periods of time (sometimes years) without spreading, although spread can occur at times
  • EPC often is associated with postictal or interictal weakness

Clonic activity in EPC can involve any muscle group and is most common in the upper extremities. Although it is typically invariant and remains localized to a single muscle group in most patients, it may be accompanied by jacksonian spread of the seizure, which may even lead to a complex partial or secondarily generalized seizure. This syndrome also may be accompanied by other neurological and psychopathological symptoms.

Bancaud’s classification

Bancaud et al classified EPC into 2 groups. Both entities start with similar seizures, but type 2 proves to be intractable and progressive.

Bancaud divided the clinical course of type 2 into 3 stages.[6] The first stage features only simple partial motor or complex partial seizures, but EPC may occur. In the second stage, EPC is seen in the setting of progressive neurologic deficit and mental deterioration. The third stage is characterized by arrest of deterioration and decrease or disappearance of seizures.

Type 1 (classic) is characterized by the following[7] :

  • Rolandic fixed lesion
  • Neurologic deficit
  • Preceding partial motor seizures
  • Following myoclonic jerks
  • Focal abnormalities on electroencephalogram (EEG)
  • Nonprogressive course
  • Surgery usually effective

Type 2 (Rasmussen) is characterized by the following:

  • Normal development and history until seizure onset
  • Preceding partial motor seizures
  • Following myoclonic jerks
  • Abnormal electroencephalographic background, with focal and diffuse paroxysmal abnormalities
  • Progressive course
  • Chronic encephalitis

Intractable epilepsy is the third classification.

Patient education

For patient information, see the Brain and Nervous System Center, as well as Epilepsy.

Next

Epidemiology

Since the first description by Kojewnikoff, a number of isolated case reports and small case series have elucidated this syndrome further. However, few epidemiologic studies have been performed.

Cockerell et al[8] estimated the prevalence of EPC at less than 1 per million, based on 36 cases reported in the United Kingdom over a 1-year period, 10 of the cases being new.

The incidence of EPC is slightly higher in males than in females.[3, 9, 8]

In a retrospective review by Sinha and Satishchandra of 76 patients with EPC at a tertiary care center in South India over the course of 14 years, the investigators found the following[10] :

  • Male-to-female ratio, 46:30
  • Mean age, 30.2+/-23.4 years
  • Median age, 26 years
Previous
Next

Etiology

The unequivocal cortical origin of EPC appears to be substantiated in humans by clinical, electrophysiologic, and neurosurgical evidence. In addition, an epileptogenic lesion of the central cortex can provoke the appearance of this phenomenon in monkeys.[6] Since surround inhibition may limit seizure spread more effectively in motor neocortex than in any other area because of the tight afferent-efferent relationships, which support the activation of long-loop reflexes, EPC may be a unique expression of cortical organization.[11, 12] However, note that seizures sometimes can be driven from distant, or even subcortical, sites.[13]

Metabolism

The EPC focus (1) is hypermetabolic, as shown by 2-deoxyglucose positron emission tomography (PET) scanning; (2) is hyperactive, as seen as by magnetoencephalogram (MEG) studies; and (3) shows increased blood flow in single-photon emission computed tomography (SPECT) scan studies.[14]

Synaptic mechanisms

Synaptic mechanisms have been studied only in self-sustaining status epilepticus, not in EPC. The author now suspects that self-sustaining status epilepticus is initiated by failure of GABAergic inhibition but is maintained by widespread potentiation of excitatory (especially N -methyl-D-aspartate [NMDA]) synapses; therefore, established self-sustaining status epilepticus becomes resistant to all agents except NMDA antagonists.[15]

The author could speculate on a similar mechanism in EPC, in which the focus would be characterized by long-term potentiation of glutamate receptors and desensitization of GABA receptors, while GABAergic inhibition would be preserved in the surround.

EPC seizures of the neocortex versus non-EPC seizures of the limbic system

The limbic system, which is involved heavily in processes such as memory and emotion, is designed to spread excitation widely and to modulate excitability in many brain regions; perhaps, as a result of this organization, seizures of limbic origin spread widely and rapidly.

By contrast, neocortex, which is involved in sensory, motor, and cognitive responses, is endowed with powerful lateral inhibition, which probably is designed to keep responses precisely localized. This may be the reason that EPC can go on for a long period of time while remaining precisely localized to a small group of muscles and a small cortical domain.

An experimental counterpart of that dichotomy is seen in the different expressions of neocortical versus limbic kindling. Limbic kindling rapidly disseminates seizures across the brain, while seizures induced by neocortex remain localized and spread widely only after gaining access to limbic circuits.

Causes of EPC

Clinical and pathologic studies have identified various causes of epilepsia partialis continua (EPC). This long list reflects the diverse nature of the pathologic processes that cause focal neocortical seizures. Nothing about these processes is specific, and the unique clinical features of EPC are likely to reflect its anatomic location rather than its etiology.

Causes of EPC associated with cerebral neoplasia include the following:

Causes of EPC associated with cortical dysplasias include the following:

Infectious or parasitic causes of EPC include the following:

  • Abscess[16]
  • Tuberculoma[3]
  • Gumma[16]
  • Russian spring-summer encephalitis[16]
  • Subacute measles encephalitis[14]
  • Human immunodeficiency virus (HIV)[21]
  • Progressive multifocal leukoencephalopathy[22]
  • Creutzfeldt-Jakob disease[8]
  • Viral encephalitis or meningo-encephalitis[16]
  • Cryptococcal meningitis[23]
  • Anti-Hu-associated paraneoplastic encephalitis[24]
  • Cysticercosis[16]
  • Granulomatous diseases[16]
  • Pertussis infection[25]

Causes of EPC associated with vascular lesions include the following:

  • Arteriosclerotic cerebrovascular disease[16]
  • Embolic or postthrombotic ischemic infarction[16]
  • Cortical venous thrombosis[16]
  • Cerebral hemorrhage[16]
  • Systemic lupus erythematosus[14]
  • Sjögren syndrome[26]
  • Arteriovenous malformation[14]
  • Carotid hypoplasia[27]

Causes of EPC associated with traumatic lesions include the following:

Drug-induced causes of EPC include the following:

Metabolic causes of EPC include the following:

Idiopathic causes of EPC include the following:

  • Rasmussen chronic encephalitis[14, 16]
  • Autoimmune - Multiple sclerosis,[34] anti-GluR3 or anti-NMDA-GluR-Epsilon2 antibodies
  • Genetic

With regard to the last item above, genetic causes include Alpers disease, Kufs disease,[35] Leigh syndrome and cytochrome C oxidase deficiency,[36] nicotinamide adenine dinucleotide (NADH) coenzyme Q reductase deficiency,[37] and mitochondrial cytopathies, including mitochondrial encephalopathy with lactic acidosis and stroke (MELAS)[38]

Previous
Next

Electroencephalography

Neurologic evaluation is essential in view of the variety of etiologies and associated illnesses in patients with epilepsia partialis continua (EPC).

In general, electroencephalography has not been successful in determining the origin of EPC. In Rasmussen encephalitis, the EEG often shows significant lateralized, slow-wave activity, and it may give evidence of other seizure types or projected abnormalities suggestive of widespread, but lateralized, disease. Frequently, lateralized, asymmetrical background slowing is noted.

Similar findings also can be seen with other etiologies, such as glial tumors. In the case of focal, nonprogressive pathologies, such as chronic stroke, the background is rarely as abnormal or asymmetrical. This point may help in differentiating a focal, nonprogressive pathology from structural diseases with a coexistent metabolic encephalopathy, in which the background is often diffusely abnormal.

Previous
Next

Evoked Potentials

Evoked-potential techniques, especially somatosensory evoked potentials (SSEP), have been used to examine the physiologic mechanisms and anatomical locations of EPC.[5] Giant SSEPs are seen often and point to cortical hyperexcitability, which may be an essential mechanism of EPC.

Previous
Next

PET SPECT and MRI Scans

PET and SPECT scanning are emerging as useful research tools in the evaluation of the metabolic effects of epilepsia partialis continua (EPC), especially when computed tomography (CT) and magnetic resonance imaging (MRI) scan findings are normal.

PET scan studies are also likely to enhance understanding of the biochemical and metabolic features associated with the abnormal physiology, and, consequently, they may provide significant information not only for the diagnosis of EPC but also for its treatment.[39]

MRI can point to the structural lesion of the cortex and/or white matter, and it also can follow the progression of atrophy in Bancaud type 2 EPC.[14]

SPECT-MRI fusion has been reported by Matthews to have successfully been used to identify epileptic focus in a patient with EPC.[40]

Burneo reported that ictal SPECT has also been useful in the presurgical evaluation of Rasmussen encephalitis.[41]

Previous
Next

Prognosis

The long-term prognosis of epilepsia partialis continua (EPC) depends completely on its underlying cause. The early onset of EPC in a child is often, but not always, a manifestation of neurodegenerative disease or Rasmussen encephalitis, and these conditions often are associated with progressive neurologic decline.

In patients with adult-onset EPC, the underlying cause can be fixed (eg, cortical dysplasia, stable arteriovenous malformation), self-limiting (eg, trauma, stroke), or progressive (eg, tumor, carcinomatous meningitis); the prognosis depends on the underlying pathology.

Previous
Next

Pharmacologic Treatment

Treatment should focus on the underlying condition. Antiepileptic drugs (AEDs) must be tried to prevent the spread of epilepsia partialis continua (EPC), but, with a few notable exceptions, they are unsuccessful in altering the course of EPC. Phenytoin or phenobarbital may be more effective than carbamazepine or valproate.[14] Echenne reported a case of felbamate success in a patient with hemimegalencephaly and multiple types of seizures that responded poorly to AEDs.[42]

Oral corticosteroid therapy and immunosuppression may be of some benefit in rare cases.[16] A correlation has been found between Rasmussen encephalitis and serum antibodies to the glutamate receptor subunits, GluR3[43] and NMDA-type GluR-Epsilon2.

Barrontini et al[44] reported the use of gamma globulins, but few lasting benefits have been reported to date.Nimodipine has been administered successfully in 2 cases of EPC following an acute cerebral event.[45]

Because cytomegalovirus has been implicated in the pathogenesis of Rasmussen syndrome, McLachlan et al[46] used ganciclovir and reported that EPC was controlled in one patient with this syndrome. Intraventricular interferon alpha was reported to have completely controlled EPC in a patient with Rasmussen encephalitis.

A case of successful treatment of facial myoclonus with botulinum toxin for symptomatic relief from EPC was reported by Browner.[47]

Previous
Next

Other Treatment Techniques

Transcranial magnetic stimulation has been reported to have lasting success in anecdotal cases and seems to deserve further evaluation.[48, 49] Rotenberg reported patients with epilepsia partialis continua (EPC) who benefited from transient suppression of seizures by undergoing low-frequency transcranial magnetic stimulation.[50]

Neurosurgical approaches, such as multiple subpial transections[51] , may be used as a last resort. Hemispherectomy should be considered in refractory cases of Rasmussen encephalitis.

Chronic electrical stimulation was used in 3 patients with EPC, resulting in a decrease in seizure frequency and paroxysmal discharges.

Plasma exchange has been reported to have improved EPC significantly.

Previous
 
Contributor Information and Disclosures
Author

Claude G Wasterlain, MD  Chair, Department of Neurology, VA Greater Los Angeles Health Care System; Distinguished Professor and Vice-Chair, Department of Neurology, University of California, Los Angeles, David Geffen School of Medicine

Claude G Wasterlain, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Federation for Medical Research, American Neurological Association, Royal Society of Medicine, and Society for Neuroscience

Disclosure: Nothing to disclose.

Coauthor(s)

Leo L Chen, MD  Staff Physician, Department of Neurology, University of California, Los Angeles, David Geffen School of Medicine

Leo L Chen, MD is a member of the following medical societies: American Academy of Family Physicians, American Academy of Neurology, American Medical Association, and American Medical Student Association/Foundation

Disclosure: Nothing to disclose.

Specialty Editor Board

Edward B Bromfield, MD  Associate Professor of Neurology, Faculty Member, Division of Sleep Medicine, Harvard Medical School; Chief, Division of EEG, Epilepsy and Sleep Neurology, Consulting Neurologist, Brigham and Women's Hospital

Edward B Bromfield, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, American Neurological Association, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Norberto Alvarez, MD  Assistant Professor, Department of Neurology, Harvard Medical School; Consulting Staff, Department of Neurology, Boston Children's Hospital; Medical Director, Wrentham Developmental Center

Norberto Alvarez, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, and Child Neurology Society

Disclosure: Nothing to disclose.

Chief Editor

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Guillermo Estrada, MD to the development and writing of this article.

References
  1. Bancaud J, Bonis A, Trottier S. [Continuous partial epilepsy: syndrome and disease]. Rev Neurol (Paris). 1982;138(11):803-14. [Medline].

  2. Gastaut H. [Semeiology of myoclonus and analytic nosology of myoclonic syndromes]. Rev Neurol (Paris). Jul 1968;119(1):1-30. [Medline].

  3. Juul-Jensen P, Denny-Brown D. Epilepsia partialis continua. Arch Neurol. Dec 1966;15(6):563-78. [Medline].

  4. Bancaud J, Bonis A, Talairach J. [Kojewnikow syndrome and somato-motor attacks (clinical, E.E.G., E.M.G. and S.E.E.G. study)]. Encephale. Sep-Oct 1970;59(5):391-438. [Medline].

  5. Shomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia. 1993;34(Suppl 1):S29-S36.

  6. Bancaud J. Kojewnikow's syndrome (epilepsia partialis continua) in children. In: Rojer j, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence. 2nd ed. London: John Libbey;1992:363-79.

  7. Svein I, Johannessen Tomson, eds. Intractable Seizures and Epilepsies in Infancy and Early Childhood. Wrightson Biomedical Publishing Ltd;1995:19-20.

  8. Cockerell OC, Rothwell J, Thompson PD, et al. Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain. Apr 1996;119 ( Pt 2):393-407. [Medline].

  9. Thomas JE, Reagan TJ, Klass DW. Epilepsia partialis continua. A review of 32 cases. Arch Neurol. May 1977;34(5):266-75. [Medline].

  10. Sinha S, Satishchandra P. Epilepsia Partialis Continua over last 14 years: experience from a tertiary care center from south India. Epilepsy Res. Apr 2007;74(1):55-9. [Medline].

  11. Chauvel P, Trottier S, Vignal JP. Somatomotor seizures of frontal lobe origin. Adv Neurol. 1992;57:185-232. [Medline].

  12. Lamarche M, Chauvel P. Movement epilepsy in the monkey with an experimental motor focus. Electroencephalogr Clin Neurophysiol Suppl. 1978;(34):323-8. [Medline].

  13. Rothwell JC, Obeso JA, Marsden CD. On the significance of giant somatosensory evoked potentials in cortical myoclonus. J Neurol Neurosurg Psychiatry. Jan 1984;47(1):33-42. [Medline].

  14. Biraben A, Chauvel P. Epilepsia partialis Continua. In: Engel J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers;1998:2447-53.

  15. Mazarati AM, Wasterlain CG. Blockers of NMDA receptor restore paired-pulse inhibition in the rat dentate gyrus lesioned by perforant path stimulation. Neurosci Lett. Oct 3 1997;234(2-3):135-8. [Medline].

  16. Walker M, Shorvon S. Treatment of status epilepticus and serial seizures. In: The Treatment of Epilepsia. Blackwell Science Ltd;1996:280-2.

  17. Schomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. [Review] [51 refs]. Epilepsia. 1993;34 Suppl 1:S:29-36.

  18. Ferrer I, Pineda M, Tallada M, et al. Abnormal local-circuit neurons in epilepsia partialis continua associated with focal cortical dysplasia. Acta Neuropathol (Berl). 1992;83(6):647-52. [Medline].

  19. Kuzniecky R, Powers R. Epilepsia partialis continua due to cortical dysplasia. J Child Neurol. Oct 1993;8(4):386-8. [Medline].

  20. Norborg C, Sourander P, Silfvenius H, et al. Mild cortical dysplasia in patient with intractable partial seizures: A histological study. In: Wolf P, Dam M, Janz D, Dreifuss F, eds. Advances in Epileptology: the XVIth Epilepsy International Symposium. New York:. 1987;29-33.

  21. Bartolomei F, Gavaret M, Dhiver C. Isolated, chronic, epilepsia partialis continua in an HIV-infected patient. Arch Neurol. Jan 1999;56(1):111-4. [Medline].

  22. Ferrari S, Monaco S, Morbin M. HIV-associated PML presenting as epilepsia partialis continua. J Neurol Sci. Dec 11 1998;161(2):180-4. [Medline].

  23. Chalk CH, McManis PG, Cascino GD. Cryptococcal meningitis manifesting as epilepsia partialis continua of the abdomen. Mayo Clin Proc. Sep 1991;66(9):926-9. [Medline].

  24. Shavit YB, Graus F, Probst A, et al. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol. Feb 1999;45(2):255-8. [Medline].

  25. Komsuoglu SS, Liman O, Gurkan H. Epilepsia partialis continua following pertussis infection. Clin Electroencephalogr. Jan 1985;16(1):45-7. [Medline].

  26. Bansal SK, Sawhney IM, Chopra JS. Epilepsia partialis continua in Sjögren's syndrome. Epilepsia. Jul-Aug 1987;28(4):362-3. [Medline].

  27. Belopitova L, Bozhinova V, Khadzhibekov V. [A variant of the epilepsia partialis continua syndrome in a child with hypoplasia of the internal carotid artery]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(9):97-101 Russian. [Medline].

  28. Nobuhara K, Kagono Y, Kinoshita T. Two cases of epilepsia partialis continua associated with head trauma. Jpn J Psychiatry Neurol. Sep 1989;43(3):526-7. [Medline].

  29. Wroe SJ, Ellershaw JE, Whittaker JA, et al. Focal motor status epilepticus following treatment with azlocillin and cefotaxime. Med Toxicol. May-Jun 1987;2(3):233-4. [Medline].

  30. Shiozawa Z, Sasaki H, Ozaki Y. Epilepsia partialis continua following metrizamide cisternography. Ann Neurol. Oct 1981;10(4):400-1. [Medline].

  31. Tran, Thang X. Epilepsia partialis continua as a presenting manifestation of diabetic ketoacidosis. Ann Neurol. 1999;46(3):546.

  32. Chijioke CP, Mbah AU. Non-ketotic hyperglycaemia presenting as Epilepsia partialis continua. Cent Afr J Med. Dec 1996;42(12):349-51. [Medline].

  33. Uterga JM, Corredera C, Barrallo G, et al. [Epilepsia partialis continua: an unusual complication of liver insufficiency]. Rev Esp Enferm Dig. Oct 1995;87(10):756-7. [Medline].

  34. Spatt J, Goldenberg G, Mamoli B. Epilepsia partialis continua in multiple sclerosis. Lancet. Mar 11 1995;345(8950):658-9. [Medline].

  35. Gambardella A, Pasquinelli G, Cittadella R, Bono F, Oliveri RL, Valentino P, et al. Kufs' disease presenting as late-onset epilepsia partialis continua. Neurology. Oct 1998;51(4):1180-2. [Medline].

  36. Elia M, Musumeci SA, Ferri R, et al. Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continua. Brain Dev. May-Jun 1996;18(3):207-11. [Medline].

  37. Antozzi C, Franceschetti S, Filippini G, et al. Epilepsia partialis continua associated with NADH-coenzyme Q reductase deficiency. J Neurol Sci. Apr 1995;129(2):152-61. [Medline].

  38. Veggiotti P, Colamaria V, Dalla Bernardina B. Epilepsia partialis continua in a case of MELAS: clinical and neurophysiological study. Neurophysiol Clin. 1995;25(3):158-66. [Medline].

  39. Yoshida T, Tanaka M, Masuda T. [Epilepsia partialis continua with an epileptic focus demonstrated by PET and unique MRI findings: report of a case]. Rinsho Shinkeigaku. Sep 1995;35(9):1021-4. [Medline].

  40. Matthews R, Franceschi D, Xia W, Cabahug C, Schuman G, Bernstein R. Parietal lobe epileptic focus identified on SPECT-MRI fusion imaging in a case of epilepsia partialis continua. Clin Nucl Med. Dec 2006;31(12):826-8. [Medline].

  41. Burneo JG, Hamilton M, Vezina W, Parrent A. Utility of Ictal SPECT in the presurgical evaluation of Rasmussen's encephalitis. Can J Neurol Sci. Feb 2006;33(1):107-10. [Medline].

  42. Echenne B, Rivier F, Roubertie A, et al. Successful felbamate treatment of epilepsia partialis continua in a case of hemimegalencephaly. Epilepsia. 1997;38 Supplement 3:36.

  43. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. Jul 29 1994;265(5172):648-51. [Medline].

  44. Barontini F, Maurri S, Amantini A. "Epilepsia partialis continua" due to multifocal encephalitis: favourable outcome after immunoglobulin treatment. Ital J Neurol Sci. Apr 1994;15(3):157-61. [Medline].

  45. Brandt L, Saveland H, Ljunggren B, et al. Control of epilepsy partialis continuans with intravenous nimodipine. Report of two cases. J Neurosurg. Dec 1988;69(6):949-50. [Medline].

  46. McLachlan RS, Levin S, Blume WT. Treatment of Rasmussen's syndrome with ganciclovir. Neurology. Oct 1996;47(4):925-8. [Medline].

  47. Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord. Sep 2006;21(9):1500-2. [Medline].

  48. Misawa S, Kuwabara S, Shibuya K, Mamada K, Hattori T. Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia. J Neurol Sci. Jul 15 2005;234(1-2):37-9. [Medline].

  49. Morales OG, Henry ME, Nobler MS. Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child Adolesc Psychiatr Clin N Am. Jan 2005;14(1):193-210, viii-ix. [Medline].

  50. Rotenberg A, Depositario-Cabacar D, Bae EH, Harini C, Pascual-Leone A, Takeoka M. Transient suppression of seizures by repetitive transcranial magnetic stimulation in a case of Rasmussen's encephalitis. Epilepsy Behav. Jul 2008;13(1):260-2. [Medline].

  51. Molyneux PD, Barker RA, Thom M, et al. Successful treatment of intractable epilepsia partialis continua with multiple subpial transections. J Neurol Neurosurg Psychiatry. Jul 1998;65(1):137-8. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.